Pancreatic neuroendocrine tumor staging
|
Pancreatic neuroendocrine tumor Microchapters |
|
Differentiating Pancreatic neuroendocrine tumor from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pancreatic neuroendocrine tumor staging On the Web |
|
American Roentgen Ray Society Images of Pancreatic neuroendocrine tumor staging |
|
Directions to Hospitals Treating Pancreatic neuroendocrine tumor |
|
Risk calculators and risk factors for Pancreatic neuroendocrine tumor staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Staging
The 2010 WHO classification of tumors of the digestive system grades all the neuroendocrine tumors into three categories, based on their degree of cellular differentiation (from well-differentiated "NET G1" through to poorly-differentiated "NET G3"). The NCCN recommends use of the same AJCC-UICC staging system as pancreatic adenocarcinoma. Using this scheme, the stage by stage outcomes for PanNETs are dissimilar to pancreatic exocrine cancers.[1] A different TNM system for PanNETs has been proposed by The European Neuroendocrine Tumor Society.
- Pancreatic neuroendocrine tumor staging (AJCC)
-
Stage T1
-
Stage T2
-
Stage T3
-
Stage T4
-
Involvement of nearby lymph nodes – Stage N1
-
Metastasis – stage M1
